DE69937059D1 - Antibiotische oder antiparasitäre zusammenstellungen aus anionischen oder kationischen dendrimeren - Google Patents

Antibiotische oder antiparasitäre zusammenstellungen aus anionischen oder kationischen dendrimeren

Info

Publication number
DE69937059D1
DE69937059D1 DE69937059T DE69937059T DE69937059D1 DE 69937059 D1 DE69937059 D1 DE 69937059D1 DE 69937059 T DE69937059 T DE 69937059T DE 69937059 T DE69937059 T DE 69937059T DE 69937059 D1 DE69937059 D1 DE 69937059D1
Authority
DE
Germany
Prior art keywords
anionic
moiety
antibiotic
cationic dendrimers
dendrimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69937059T
Other languages
English (en)
Other versions
DE69937059T2 (de
Inventor
Barry Ross Matthews
George Holan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Starpharma Pty Ltd
Original Assignee
Starpharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Starpharma Pty Ltd filed Critical Starpharma Pty Ltd
Publication of DE69937059D1 publication Critical patent/DE69937059D1/de
Application granted granted Critical
Publication of DE69937059T2 publication Critical patent/DE69937059T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/16—Dendrimers and dendritic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69937059T 1998-09-14 1999-09-13 Antibiotische oder antiparasitäre zusammenstellungen aus anionischen oder kationischen dendrimeren Expired - Lifetime DE69937059T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP5842A AUPP584298A0 (en) 1998-09-14 1998-09-14 Antimicrobial and antiparasitic agents
AUPP584298 1998-09-14
PCT/AU1999/000763 WO2000015240A1 (en) 1998-09-14 1999-09-13 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions

Publications (2)

Publication Number Publication Date
DE69937059D1 true DE69937059D1 (de) 2007-10-18
DE69937059T2 DE69937059T2 (de) 2008-05-29

Family

ID=3810064

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69937059T Expired - Lifetime DE69937059T2 (de) 1998-09-14 1999-09-13 Antibiotische oder antiparasitäre zusammenstellungen aus anionischen oder kationischen dendrimeren

Country Status (12)

Country Link
US (1) US6464971B1 (de)
EP (1) EP1113806B1 (de)
JP (1) JP4979848B2 (de)
KR (1) KR100720905B1 (de)
CN (2) CN101352451A (de)
AT (1) ATE372123T1 (de)
AU (1) AUPP584298A0 (de)
BR (1) BR9913712A (de)
CA (1) CA2343113C (de)
DE (1) DE69937059T2 (de)
NZ (1) NZ510289A (de)
WO (1) WO2000015240A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572459B2 (en) * 1998-09-14 2009-08-11 Starpharma Pty Ltd. Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
KR100413532B1 (ko) * 2001-02-14 2003-12-31 학교법인 포항공과대학교 폴리아민이 말단에 치환된 덴드리머 및 그 제조방법
AUPR412801A0 (en) 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
AUPR412901A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agents for the prevention and treatment of sexually transmitted disease s - II
MXPA04005611A (es) * 2001-12-11 2005-04-19 Cellgate Inc Reactivos y conjugados de transporte de guanidinio.
WO2004019993A1 (en) * 2002-08-30 2004-03-11 Ramot At Tel Aviv University Ltd. Self-immolative dendrimers releasing many active moieties upon a single activating event
US20040234496A1 (en) * 2003-02-06 2004-11-25 Stockel Richard F. Biocidal compositions
US7074459B2 (en) * 2003-05-23 2006-07-11 Stockel Richard F Method for preserving wood
FR2862650B1 (fr) * 2003-11-24 2007-04-20 Rhodia Cons Spec Ltd Nouveaux dendrimeres a terminaisons monophosphoniques, leur procede de preparation et leur utilisation
FR2862651B1 (fr) * 2003-11-24 2006-03-31 Rhodia Cons Spec Ltd Nouveaux dendrimeres a terminaisons bisphosphoniques et derives, leur procede de preparation et leur utilisation
CN1296711C (zh) * 2004-05-14 2007-01-24 沈阳迈迪生物医学技术有限公司 乳腺癌的Her－2免疫组织化学诊断试剂盒
JP4553354B2 (ja) * 2004-10-04 2010-09-29 正隆 井原 抗トリパノソーマ剤
US8790672B2 (en) * 2005-02-22 2014-07-29 Nina M. Lamba-Kohli Generation of antimicrobial surfaces using dendrimer biocides
US20060269480A1 (en) * 2005-05-31 2006-11-30 Ramot At Tel Aviv University Ltd. Multi-triggered self-immolative dendritic compounds
US20100298403A1 (en) * 2005-07-08 2010-11-25 Janssen Pharmaceutica N.V. MODIFIED POLY(PROPYLENE-IMINE) DENDRIMERS AND THEIR USE AS TRANSFECTION AGENTS FOR AMIONIC BIOACTIVE FACTORS ( as amended
KR20140027528A (ko) * 2005-10-18 2014-03-06 스타파마 피티와이 리미티드 살미생물성 덴드리머 조성물 전달 시스템
WO2007045010A1 (en) * 2005-10-21 2007-04-26 Starpharma Pty Limited Inhibitory compounds
NZ569756A (en) * 2005-12-12 2011-07-29 Allaccem Inc Methods and systems for preparing antimicrobial films and coatings utilising polycyclic bridged ammonium salts
ES2937113T3 (es) 2006-01-20 2023-03-24 Starpharma Pty Ltd Macromolécula modificada
AU2007229268B2 (en) * 2006-03-22 2013-01-10 Starpharma Pty Limited Contraceptive composition
ES2522908T3 (es) 2007-02-21 2014-11-19 Allaccem, Inc. Composiciones a base de compuestos policíclicos con puente para la inhibición y el alivio de enfermedades
US20080282480A1 (en) * 2007-05-15 2008-11-20 The Hong Kong Polytechnic University Multifunction Finishing Liquids Containing Dendrimers and the Application of the Liquids in Textile Finishing
US20090001802A1 (en) * 2007-05-21 2009-01-01 Diallo Mamadou S Extraction of Actinides From Mixtures and Ores Using Dendritic Macromolecules
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100008864A1 (en) * 2008-07-10 2010-01-14 Andreas Meijer Aromatic multimers
US9815712B2 (en) 2008-10-03 2017-11-14 California Institute Of Technology High capacity perchlorate-selective resins from hyperbranched macromolecules
WO2010040117A2 (en) * 2008-10-03 2010-04-08 California Institute Of Technology Extraction of anions from solutions and mixtures using hyperbranched macromolecules
EP2450392B1 (de) 2009-07-01 2014-06-25 Japan Science And Technology Agency Polyionisches dendrimer und hydrogel dies umfassend
JP5212656B2 (ja) * 2009-09-02 2013-06-19 日産化学工業株式会社 イソチオシアナト化合物の製造方法
US8658702B2 (en) 2009-12-17 2014-02-25 Mamadou Diallo Soluble anion exchangers from hyperbranched macromolecules
CN103179855B (zh) * 2010-06-30 2015-07-08 刘慧文 抗菌化合物
RU2478106C2 (ru) * 2010-11-25 2013-03-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) СОЕДИНЕНИЯ НА ОСНОВЕ КОМПЛЕКСОВ ГИПЕРРАЗВЕТВЛЕННЫХ ПОЛИМЕРОВ Boltorn H, ОБЛАДАЮЩИЕ АНТИКАНДИДОЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
US9102602B2 (en) 2010-11-29 2015-08-11 Nissan Chemical Industries, Ltd. Method for producing isothiocyanate compound
RU2632110C2 (ru) * 2011-05-16 2017-10-02 Старфарма Пти Лтд Способ лечения или профилактики бактериального вагиноза
WO2013074526A2 (en) 2011-11-15 2013-05-23 Byocoat Enterprises, Inc. Antimicrobial compositions and methods of use thereof
CN105007910B (zh) * 2012-09-13 2019-03-19 星法马有限公司 眼部感染的治疗或预防药物的制造用途
WO2014130655A2 (en) * 2013-02-20 2014-08-28 Biolog, Inc. Compositions and methods to inactivate and/or reduce production of microbial toxins
AU2014237232B9 (en) * 2013-03-15 2018-02-01 Genzyme Corporation Amine functional polyamides
GB201405660D0 (en) * 2014-03-28 2014-05-14 Gama Healthcare Ltd A liquid disinfecting composition
CN103999853B (zh) * 2014-06-11 2015-07-22 中国农业大学 荧光树枝状纳米大分子在制备药物载体中的应用
US9854806B2 (en) 2015-05-19 2018-01-02 International Business Machines Corporation Antimicrobial guanidinium and thiouronium functionalized polymers
EA039370B1 (ru) * 2016-04-14 2022-01-19 Мериал, Инк. Иммуногенная многодозовая композиция, содержащая антимикробный полиамидный консервант
US11154589B2 (en) 2016-11-02 2021-10-26 The University Of Melbourne Antimicrobial composition combinations comprising star shaped peptide polymers
US10953039B2 (en) 2018-09-27 2021-03-23 International Business Machines Corporation Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
CN110041523B (zh) * 2019-04-15 2021-04-30 同济大学 低代树枝状聚赖氨酸类抗菌肽及其制备方法
CN114053392A (zh) * 2020-07-30 2022-02-18 广州朗圣药业有限公司 新型化合物在制备预防和/或治疗hpv感染的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM623994A0 (en) 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US5658574A (en) * 1995-10-13 1997-08-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cleansing compositions with dendrimers as mildness agents
DE19624705A1 (de) 1996-06-20 1998-01-08 Deutsches Krebsforsch Dendrimere auf Saccharid-Basis
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
WO1998026662A1 (en) 1996-12-19 1998-06-25 The Penn State Research Foundation Compounds and methods for treating and preventing bacterial and viral disease
AUPP584398A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Inhibition of toxic materials or substances

Also Published As

Publication number Publication date
WO2000015240A1 (en) 2000-03-23
AUPP584298A0 (en) 1998-10-08
JP2002524524A (ja) 2002-08-06
CN101352451A (zh) 2009-01-28
KR20010075066A (ko) 2001-08-09
JP4979848B2 (ja) 2012-07-18
BR9913712A (pt) 2001-05-29
EP1113806A4 (de) 2003-06-25
CN1323214A (zh) 2001-11-21
NZ510289A (en) 2002-10-25
US6464971B1 (en) 2002-10-15
EP1113806A1 (de) 2001-07-11
DE69937059T2 (de) 2008-05-29
KR100720905B1 (ko) 2007-05-25
EP1113806B1 (de) 2007-09-05
CA2343113A1 (en) 2000-03-23
CA2343113C (en) 2009-11-24
ATE372123T1 (de) 2007-09-15

Similar Documents

Publication Publication Date Title
DE69937059D1 (de) Antibiotische oder antiparasitäre zusammenstellungen aus anionischen oder kationischen dendrimeren
Legrand et al. A critical review of the roles of host lactoferrin in immunity
DE69426727D1 (de) Antimikrobielle zusammensetzungen für abwischtücher
CA2326510A1 (en) Dextran formulations and method for treatment of inflammatory joint disorders
IL130823A (en) Peptide-lipid conjugates, liposomes drug delivery
NZ306653A (en) Isolated dna il-17 receptors
BR0307893A (pt) Formulação oftálmica com sistema de goma
ATE249839T1 (de) Immunstimulierende oligodeoxynukleotide
CA2211118A1 (en) Stable lipid-comprising drug delivery complexes and methods for their production
EP1570840A3 (de) Topische Zusammensetzung mit N-Acetylaldosaminen oder N-Acetylaminosäuren
DE50212276D1 (de) Antiinfektive kohlenhydrate
WO2006006195B1 (en) Antibacterial peptides and analogues thereof
BR9914998A (pt) Antibióticos macrólidos
KR970703357A (ko) 병원체-저해제로서의, 측쇄를 가지는 올리고누클레오티드(branched oligonu-cleotides as pathogen-inhibitory agents)
WO1995032986B1 (en) Branched oligonucleotides as pathogen-inhibitory agents
WO2004011477A3 (en) 6,11-4-carbon bridged ketolides
BR9812577A (pt) Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar infecções bacterianas
BR9812148A (pt) Derivados de eritromicina 6,9-ligados em ponte
WO2003032985A3 (en) Concomitant oral and topical administration of anti - infective agents
WO2003094842A3 (en) Conjugates comprising central nervous system active drug
EP1114826A3 (de) Antibakterielle und prokinetische Makroliden
CA2332686A1 (en) Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
Kusser et al. Characteristics of the binding of aminoglycoside antibiotics to teichoic acids: a potential model system for interaction of aminoglycosides with polyanions
PT981355E (pt) Tratamento de doencas inflamatorias cronicas com toxina de gbs/cm101

Legal Events

Date Code Title Description
8364 No opposition during term of opposition